The effect of low-dose aspirin (100 mg daily) on in vivo platelet activation
colorectal 134, prostate
PROSTATE
At the end of the run-in period, urine samples from 522 participants were available (breast 193, colorectal 134, gastro-oesophageal 35, prostate 160) with 8 participants excluded due to reported poor adherence. Characteristics of participants who provided samples at the end of run-in were similar to the overall study cohort except that there were slightly fewer ex/current smokers (data not shown). Aspirin 100 mg daily suppressed U-TXM excretion similarly across all four cohorts (Fig. 